Ryukakusan

Ryukakusan Co. is a Tokyo-based Japanese pharmaceutical company whose brand identity is closely associated with throat care, cough relief, and products intended to support swallowing. Its best-known product is Ryukakusan, a fine herbal powder sold as a Japanese class III over-the-counter medicine. The company also markets direct-use powder and troche products, throat refreshers, and swallowing-aid jelly. The brand traces its origins to an early-modern Kampo cough remedy used by physicians serving the Satake Clan in the Akita Domain. The original preparation was associated with the Fuji family of physicians and was named Ryukakusan, a term commonly rendered as “dragon antler powder,” in reference to ingredients in the historical formulation, including dragon bone, deer antler powder, and borneol. Shoteiji Fujii began making the medicine available to the general public in 1871. In 1894, his son Tokusaburo revised the formula and introduced the fine herbal powder form that became central to the modern product identity. Ryukakusan occupies a distinctive position between traditional Japanese medicine and contemporary consumer healthcare. Rather than presenting itself only as a conventional pharmaceutical manufacturer, the company has built recognition around a familiar preparation format, heritage-based formulation, and specialized focus on the throat and swallowing experience. The portfolio includes products that can be taken without water, a useful feature for consumers seeking relief while speaking, traveling, or away from home. The company also extends beyond conventional lozenges through jelly-based swallowing support and food-category throat refreshers. The company experienced financial pressure during the 1990s. In 1995, it reportedly carried approximately ¥4 billion in debt. A significant recovery measure was the sale of Iatron Laboratory to Mitsubishi in 2002. The available reference material does not provide a complete account of the company’s later financial performance, ownership structure, or current management, so those details remain unspecified here. Ryukakusan products have developed substantial recognition outside Japan, particularly in China and Taiwan. Chinese consumers and visitors to Japan have purchased the products for personal use and, at times, in bulk for family members or resale. Interest increased sharply in China in 2015 after online commentary described the product as especially effective for throat discomfort associated with air pollution. This popularity also created regulatory and distribution challenges, including a 2016 arrest in Japan connected to suspected unauthorized resale and the 2017 removal of several Japanese medicines, including Ryukakusan products, from Taobao because of authorization concerns. A Chinese copycat product using the name “Ryu-no-san” was reported in 2019. Today, Ryukakusan remains an active Japanese healthcare brand with a concentrated specialization in throat and swallowing products. Its historical continuity, recognizable powder format, and visibility among Asian consumers distinguish it from broader pharmaceutical companies with more diversified portfolios.

Ryukakusan’s documented public identity in the supplied material is that of a Japanese throat-care brand linked to Ryukakusan Co., Ltd. The brand is associated with traditional Chinese medicine-inspired and Kampo-related approaches to throat and cough care, and its consumer recognition is built around products designed for throat irritation, hoarseness and coughing. The available references do not provide a sufficiently reliable chronology for the company’s establishment, the origin of the name, the identity of its founder or the development of its product portfolio. Those fields therefore remain unconfirmed rather than being inferred from general descriptions of the brand. The same limitation applies to ownership, headquarters, executive appointments and overseas expansion. Within its visible product identity, Ryukakusan uses several delivery formats. Powdered preparations represent the brand’s distinctive traditional-style experience, while throat candies or lozenges and granulated products broaden convenience and everyday usability. This format diversity allows the brand to address consumers seeking a familiar throat-care product in either a powder or confectionery-style form, without treating every item as identical in regulatory status or formulation. The company’s official website presents the brand through a Japanese consumer-health message centered on coughing and throat discomfort. That presentation supports Ryukakusan’s current positioning as a specialized throat-care name rather than a broad general-health brand. No reliable source supplied for this entry establishes specific historical campaigns, scandals, acquisitions, financial results, listing information or senior-management changes. The history should therefore be expanded only when primary corporate records or dependable independent references become available.

• Development of a Japanese throat-care identity

  [1]Ryukakusan official websiteryukakusan.co.jp

  Ryukakusan became associated with throat and cough care through powdered, lozenge and granulated product formats. A verified date for this development was not available in the supplied references.

Japanese throat-care and cough-remedy brand with traditional Chinese medicine-inspired and Kampo-related associations.

• Throat and cough remedy

  Ryukakusan powder

  A powdered throat-care format associated with the Ryukakusan name. It represents the brand’s traditional-style product experience and is positioned for use when consumers experience throat discomfort or coughing. The supplied material does not establish a complete ingredient list, launch date or market-by-market regulatory classification.

• Throat lozenge and candy

  Ryukakusan throat lozenges and candies

  Lozenge and candy formats extend Ryukakusan’s throat-care positioning into a portable, familiar consumer format. They are associated with soothing or refreshing the throat, but the exact formulation, claims and availability depend on the specific product and market.

• Granulated throat and cough preparation

  Ryukakusan granulated preparations

  Granulated products provide another oral format within the brand’s throat and cough-care portfolio. They are grouped here at the format level because the supplied references do not identify a complete product catalogue or provide reliable launch dates for individual variants.

• 2019

  Copycat product using the name Ryu-no-san reported in China[2]中国出现名为“Ryu-no-san”的仿冒产品en.wikipedia.org

  Other

  A Chinese product called Ryu-no-san was reported as a copycat of Ryukakusan, reflecting the brand’s popularity and the risks associated with imitation products in overseas markets.

• 2017

  Taobao removes Ryukakusan and other Japanese medicines over authorization concerns[2]中国出现名为“Ryu-no-san”的仿冒产品en.wikipedia.org

  Regulation

  Taobao delisted a number of Japanese medicines, including Ryukakusan, because they reportedly lacked the required authorization for sale on the platform.

• 2016

  Person arrested in Japan over suspected unauthorized Ryukakusan resale[2]中国出现名为“Ryu-no-san”的仿冒产品en.wikipedia.org

  Regulation

  A Chinese individual was arrested in Japan on suspicion of illegally purchasing Ryukakusan products for resale, illustrating the pressures created by cross-border demand.

• 2015

  Ryukakusan gains major popularity in China amid air-pollution concerns[2]中国出现名为“Ryu-no-san”的仿冒产品en.wikipedia.org

  Other

  Online discussion in China reportedly described Ryukakusan as a highly effective remedy for sore throat symptoms associated with air pollution, driving increased consumer interest.

1. 1Ryukakusan official websiteryukakusan.co.jp
2. 2中国出现名为“Ryu-no-san”的仿冒产品en.wikipedia.org